A detailed history of Schroder Investment Management Group transactions in Novo Nordisk A S stock. As of the latest transaction made, Schroder Investment Management Group holds 7,523 shares of NVO stock, worth $639,680. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,523
Previous 7,523 -0.0%
Holding current value
$639,680
Previous $1.07 Million 16.59%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$122.71 - $146.91 $127,618 - $152,786
1,040 Added 16.04%
7,523 $1.07 Million
Q1 2024

May 14, 2024

SELL
$102.11 - $135.92 $206,568 - $274,966
-2,023 Reduced 23.78%
6,483 $832,000
Q4 2023

Feb 13, 2024

SELL
$87.78 - $105.45 $10,533 - $12,654
-120 Reduced 1.39%
8,506 $879,000
Q3 2023

Nov 14, 2023

BUY
$90.94 - $199.54 $395,407 - $867,599
4,348 Added 101.64%
8,626 $784,000
Q2 2023

Aug 11, 2023

BUY
$155.98 - $172.65 $30,572 - $33,839
196 Added 4.8%
4,278 $692,000
Q1 2023

May 11, 2023

BUY
$132.34 - $159.14 $794 - $954
6 Added 0.15%
4,082 $649,000
Q4 2022

Feb 10, 2023

BUY
$102.55 - $135.33 $7,793 - $10,285
76 Added 1.9%
4,076 $551,000
Q3 2022

Nov 10, 2022

SELL
$95.28 - $116.93 $52,594 - $64,545
-552 Reduced 12.13%
4,000 $402,000
Q1 2022

May 16, 2022

BUY
$93.1 - $112.54 $51,391 - $62,122
552 Added 13.8%
4,552 $505,000
Q4 2021

Feb 14, 2022

BUY
$95.88 - $117.08 $383,520 - $468,320
4,000 New
4,000 $448,000
Q3 2021

Nov 12, 2021

SELL
$84.42 - $106.62 $6.75 Million - $8.53 Million
-80,000 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$67.66 - $84.76 $5.14 Million - $6.44 Million
76,000 Added 1900.0%
80,000 $6.7 Million
Q1 2019

May 14, 2019

BUY
$46.36 - $52.63 $185,440 - $210,520
4,000 New
4,000 $209,000
Q4 2018

Feb 14, 2019

SELL
$41.54 - $47.25 $166,160 - $189,000
-4,000 Closed
0 $0
Q2 2018

Aug 13, 2018

BUY
$44.29 - $50.42 $177,160 - $201,680
4,000 New
4,000 $182,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $192B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Schroder Investment Management Group Portfolio

Follow Schroder Investment Management Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

News

Stay updated on Schroder Investment Management Group with notifications on news.